Dementia Care in St. Louis, MO

Schedule A Tour

Donanemab: The Newest Drug in the Artillery

Eli Lilly and Company’s experimental intravenous drug donanemab may slow the cognitive decline of patients with Alzheimer’s disease, according to early clinical trial results, published in The New England Journal of Medicine on March 6th, 2021. The study...